Su B - Search Results

1

Polymorphisms of CCNB1 Associated With the Clinical Outcomes of Platinum-Based Chemotherapy in Chinese NSCLC Patients.

Liu D, Xu W, Ding X, Yang Y, Su B, Fei K. Liu D, et al. Among authors: su b. J Cancer. 2017 Oct 17;8(18):3785-3794. doi: 10.7150/jca.21151. eCollection 2017. J Cancer. 2017. PMID: 29151966 Free PMC article.

2

Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft models.

Xu QH, Shi JY, Zhang J, Sun YF, Chang AH, Zhao YM, Cai WJ, Liu D, Zhou CC, Fan LH, Su B. Xu QH, et al. Among authors: su b. Clin Transl Oncol. 2014 Apr;16(4):395-401. doi: 10.1007/s12094-013-1091-4. Epub 2013 Aug 27. Clin Transl Oncol. 2014. PMID: 23979910

3

Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.

Tan X, Wu Q, Cai Y, Zhao X, Wang S, Gao Z, Yang Y, Li X, Qian J, Wang J, Su B, Chen H, Han B, Jiang G, Lu D. Tan X, et al. Among authors: su b. Clin Lung Cancer. 2014 Jan;15(1):67-78.e12. doi: 10.1016/j.cllc.2013.08.006. Epub 2013 Nov 9. Clin Lung Cancer. 2014. PMID: 24220096

4

Snapback primer mediated clamping PCR for detection of EGFR and KRAS mutations in NSCLC patients by high resolution melting analysis.

Sun H, Yang Y, Yang L, Su B, Jiang G, Fei K, Lu D. Sun H, et al. Among authors: su b. Biomed Res Int. 2014;2014:407537. doi: 10.1155/2014/407537. Epub 2014 May 4. Biomed Res Int. 2014. PMID: 24883309 Free PMC article.

5

Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients.

Cai W, Chen C, Li X, Shi J, Sun Q, Liu D, Sun Y, Hou L, Zhao X, Gu S, Wu Q, Chen H, Zhang W, Jin L, Lu D, Fei K, Su B, Qian J. Cai W, et al. Among authors: su b. Future Oncol. 2014 May;10(7):1175-85. doi: 10.2217/fon.14.25. Future Oncol. 2014. PMID: 24947259

6

High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC.

Wu CY, Hou LK, Ren SX, Su B, Chen G. Wu CY, et al. Among authors: su b. Asian Pac J Cancer Prev. 2014;15(18):7885-9. doi: 10.7314/apjcp.2014.15.18.7885. Asian Pac J Cancer Prev. 2014. PMID: 25292082 Free article.

7

RB1 polymorphism contributes to the efficacy of platinum-taxanes in advanced squamous cell lung cancer.

Liu D, Xu W, Zhang ZW, Qian J, Zheng H, Zhang J, Su B. Liu D, et al. Among authors: su b. Asian Pac J Cancer Prev. 2015;16(2):775-81. doi: 10.7314/apjcp.2015.16.2.775. Asian Pac J Cancer Prev. 2015. PMID: 25684524 Free article.

8

WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients.

Liu D, Wu C, Jiao Y, Hou L, Lu D, Zheng H, Chen C, Qian J, Fei K, Su B. Liu D, et al. Among authors: su b. Sci Rep. 2015 Jun 9;5:11114. doi: 10.1038/srep11114. Sci Rep. 2015. PMID: 26057002 Free PMC article.

9

PTEN polymorphisms contribute to clinical outcomes of advanced lung adenocarcinoma patients treated with platinum-based chemotherapy.

Yang Y, Xu W, Liu D, Ding X, Su B, Sun Y, Gao W. Yang Y, et al. Among authors: su b. Tumour Biol. 2016 Jun;37(6):7785-96. doi: 10.1007/s13277-015-4651-0. Epub 2015 Dec 22. Tumour Biol. 2016. PMID: 26695147

10

Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy.

Yang Y, Gao W, Ding X, Xu W, Liu D, Su B, Sun Y. Yang Y, et al. Among authors: su b. Oncotarget. 2017 Mar 7;8(10):16313-16324. doi: 10.18632/oncotarget.10771. Oncotarget. 2017. PMID: 27462918 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,696 results

Search Page

Filters